Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial.
Journal: Pediatric hematology and oncology
Published: December 10, 2024
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: December 22, 2023
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial.
Journal: Pulmonary therapy
Published: February 10, 2021
Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects.
Journal: Journal of pediatric surgery
Published: March 29, 2018
Three Interventions That Reduce Childhood Obesity Are Projected To Save More Than They Cost To Implement.
Journal: Health affairs (Project Hope)
Published: November 04, 2015
The Relationship between Obesity and Cognitive Performance in Children: A Longitudinal Study.
Journal: Childhood obesity (Print)
Published: August 11, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026